Vision-Ease Lens Corporation withdrew its IPO filing today,citing the decision is “consistent with the public interest and protection ofinvestors.” The company originally submitted its IPO paperwork to the SEC on October 13, 2006.
The companyplanned to trade on the Nasdaq Global Market under the symbol “VELS.” The underwritersfor the deal were JPMorgan, William Blair and Company, BMO Capital Markets, andRobert W. Baird and Co.
Vision-Ease designs, manufactures, and distributespolycarbonate prescription lenses globally. They have a patent for LifeRx, a lensthat darkens when exposed to UV rays. With its experience and strategy,Vision-Ease believed its competitive place in the prescription lens marketwould be a good investment for shareholders. They are seeing a new worldthrough those patented lenses and changed their mind.
Rachel Lopez
March 20, 2008
Sponsored: Want to Retire Early? Start Here
Want retirement to come a few years earlier than you’d planned? Orare you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
